nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—CES2—Irinotecan—stomach cancer	0.27	0.391	CbGbCtD
Dabigatran etexilate—CES1—Capecitabine—stomach cancer	0.152	0.22	CbGbCtD
Dabigatran etexilate—CES1—Irinotecan—stomach cancer	0.0937	0.136	CbGbCtD
Dabigatran etexilate—UGT1A9—Irinotecan—stomach cancer	0.0569	0.0825	CbGbCtD
Dabigatran etexilate—UGT2B7—Epirubicin—stomach cancer	0.0553	0.0803	CbGbCtD
Dabigatran etexilate—ABCB1—Mitomycin—stomach cancer	0.036	0.0522	CbGbCtD
Dabigatran etexilate—F2—hepatic artery—stomach cancer	0.0174	0.182	CbGeAlD
Dabigatran etexilate—F2—portal vein—stomach cancer	0.0151	0.158	CbGeAlD
Dabigatran etexilate—ABCB1—Irinotecan—stomach cancer	0.00923	0.0134	CbGbCtD
Dabigatran etexilate—F2—vein—stomach cancer	0.00871	0.0908	CbGeAlD
Dabigatran etexilate—ABCB1—Docetaxel—stomach cancer	0.00676	0.00981	CbGbCtD
Dabigatran etexilate—ABCB1—Doxorubicin—stomach cancer	0.00504	0.00731	CbGbCtD
Dabigatran etexilate—ABCB1—Methotrexate—stomach cancer	0.00488	0.00709	CbGbCtD
Dabigatran etexilate—UGT2B15—gall bladder—stomach cancer	0.00475	0.0495	CbGeAlD
Dabigatran etexilate—F2—blood vessel—stomach cancer	0.00276	0.0288	CbGeAlD
Dabigatran etexilate—F2—gall bladder—stomach cancer	0.0026	0.0271	CbGeAlD
Dabigatran etexilate—CES1—gall bladder—stomach cancer	0.00239	0.0249	CbGeAlD
Dabigatran etexilate—UGT2B15—pancreas—stomach cancer	0.00219	0.0228	CbGeAlD
Dabigatran etexilate—UGT2B15—digestive system—stomach cancer	0.00187	0.0195	CbGeAlD
Dabigatran etexilate—CES2—hematopoietic system—stomach cancer	0.00164	0.0171	CbGeAlD
Dabigatran etexilate—UGT2B15—endocrine gland—stomach cancer	0.00154	0.0161	CbGeAlD
Dabigatran etexilate—F2—hematopoietic system—stomach cancer	0.00147	0.0153	CbGeAlD
Dabigatran etexilate—CES2—smooth muscle tissue—stomach cancer	0.00145	0.0151	CbGeAlD
Dabigatran etexilate—UGT1A9—digestive system—stomach cancer	0.00142	0.0148	CbGeAlD
Dabigatran etexilate—UGT2B15—liver—stomach cancer	0.00139	0.0145	CbGeAlD
Dabigatran etexilate—CES1—hematopoietic system—stomach cancer	0.00135	0.0141	CbGeAlD
Dabigatran etexilate—F2—epithelium—stomach cancer	0.00135	0.014	CbGeAlD
Dabigatran etexilate—CES2—pancreas—stomach cancer	0.00134	0.0139	CbGeAlD
Dabigatran etexilate—NQO2—pancreas—stomach cancer	0.00119	0.0124	CbGeAlD
Dabigatran etexilate—UGT1A9—endocrine gland—stomach cancer	0.00117	0.0122	CbGeAlD
Dabigatran etexilate—UGT2B7—digestive system—stomach cancer	0.00114	0.0119	CbGeAlD
Dabigatran etexilate—CES2—digestive system—stomach cancer	0.00114	0.0119	CbGeAlD
Dabigatran etexilate—UGT1A9—liver—stomach cancer	0.00105	0.011	CbGeAlD
Dabigatran etexilate—CES2—bone marrow—stomach cancer	0.00105	0.011	CbGeAlD
Dabigatran etexilate—F2—lymphoid tissue—stomach cancer	0.00104	0.0108	CbGeAlD
Dabigatran etexilate—F2—digestive system—stomach cancer	0.00102	0.0107	CbGeAlD
Dabigatran etexilate—CES1—lymphoid tissue—stomach cancer	0.000952	0.00992	CbGeAlD
Dabigatran etexilate—F2—bone marrow—stomach cancer	0.000944	0.00983	CbGeAlD
Dabigatran etexilate—UGT2B7—endocrine gland—stomach cancer	0.000943	0.00983	CbGeAlD
Dabigatran etexilate—CES2—endocrine gland—stomach cancer	0.000943	0.00983	CbGeAlD
Dabigatran etexilate—NQO2—bone marrow—stomach cancer	0.00094	0.0098	CbGeAlD
Dabigatran etexilate—CES1—digestive system—stomach cancer	0.00094	0.00979	CbGeAlD
Dabigatran etexilate—CES2—liver—stomach cancer	0.00085	0.00886	CbGeAlD
Dabigatran etexilate—UGT2B7—liver—stomach cancer	0.00085	0.00886	CbGeAlD
Dabigatran etexilate—F2—endocrine gland—stomach cancer	0.000846	0.00881	CbGeAlD
Dabigatran etexilate—NQO2—endocrine gland—stomach cancer	0.000843	0.00878	CbGeAlD
Dabigatran etexilate—CES1—endocrine gland—stomach cancer	0.000777	0.00809	CbGeAlD
Dabigatran etexilate—F2—liver—stomach cancer	0.000763	0.00795	CbGeAlD
Dabigatran etexilate—NQO2—liver—stomach cancer	0.00076	0.00792	CbGeAlD
Dabigatran etexilate—CES1—liver—stomach cancer	0.0007	0.0073	CbGeAlD
Dabigatran etexilate—CES2—lymph node—stomach cancer	0.000652	0.00679	CbGeAlD
Dabigatran etexilate—ABCB1—blood vessel—stomach cancer	0.000594	0.0062	CbGeAlD
Dabigatran etexilate—NQO2—lymph node—stomach cancer	0.000583	0.00607	CbGeAlD
Dabigatran etexilate—CES1—lymph node—stomach cancer	0.000537	0.00559	CbGeAlD
Dabigatran etexilate—ABCB1—hematopoietic system—stomach cancer	0.000317	0.0033	CbGeAlD
Dabigatran etexilate—ABCB1—epithelium—stomach cancer	0.000289	0.00302	CbGeAlD
Dabigatran etexilate—ABCB1—pancreas—stomach cancer	0.000258	0.00269	CbGeAlD
Dabigatran etexilate—ABCB1—lymphoid tissue—stomach cancer	0.000223	0.00232	CbGeAlD
Dabigatran etexilate—ABCB1—digestive system—stomach cancer	0.00022	0.00229	CbGeAlD
Dabigatran etexilate—ABCB1—bone marrow—stomach cancer	0.000203	0.00211	CbGeAlD
Dabigatran etexilate—ABCB1—endocrine gland—stomach cancer	0.000182	0.0019	CbGeAlD
Dabigatran etexilate—ABCB1—liver—stomach cancer	0.000164	0.00171	CbGeAlD
Dabigatran etexilate—Infestation NOS—Methotrexate—stomach cancer	0.000145	0.00123	CcSEcCtD
Dabigatran etexilate—Infestation—Methotrexate—stomach cancer	0.000145	0.00123	CcSEcCtD
Dabigatran etexilate—Gastritis—Doxorubicin—stomach cancer	0.000145	0.00122	CcSEcCtD
Dabigatran etexilate—Alanine aminotransferase increased—Doxorubicin—stomach cancer	0.000144	0.00122	CcSEcCtD
Dabigatran etexilate—Upper respiratory tract infection—Epirubicin—stomach cancer	0.000142	0.0012	CcSEcCtD
Dabigatran etexilate—Urticaria—Fluorouracil—stomach cancer	0.000142	0.0012	CcSEcCtD
Dabigatran etexilate—Syncope—Docetaxel—stomach cancer	0.000141	0.0012	CcSEcCtD
Dabigatran etexilate—Influenza—Doxorubicin—stomach cancer	0.000141	0.0012	CcSEcCtD
Dabigatran etexilate—Dysphagia—Doxorubicin—stomach cancer	0.000141	0.0012	CcSEcCtD
Dabigatran etexilate—Anaemia—Capecitabine—stomach cancer	0.000141	0.0012	CcSEcCtD
Dabigatran etexilate—Palpitations—Docetaxel—stomach cancer	0.000139	0.00118	CcSEcCtD
Dabigatran etexilate—Haematuria—Methotrexate—stomach cancer	0.000139	0.00117	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Docetaxel—stomach cancer	0.000139	0.00117	CcSEcCtD
Dabigatran etexilate—Cough—Docetaxel—stomach cancer	0.000138	0.00117	CcSEcCtD
Dabigatran etexilate—Angina pectoris—Doxorubicin—stomach cancer	0.000138	0.00117	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Methotrexate—stomach cancer	0.000138	0.00116	CcSEcCtD
Dabigatran etexilate—Epistaxis—Methotrexate—stomach cancer	0.000137	0.00116	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Irinotecan—stomach cancer	0.000137	0.00116	CcSEcCtD
Dabigatran etexilate—Syncope—Capecitabine—stomach cancer	0.000137	0.00116	CcSEcCtD
Dabigatran etexilate—Pneumonia—Epirubicin—stomach cancer	0.000137	0.00116	CcSEcCtD
Dabigatran etexilate—Hypertension—Docetaxel—stomach cancer	0.000136	0.00115	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Epirubicin—stomach cancer	0.000136	0.00115	CcSEcCtD
Dabigatran etexilate—Infestation—Epirubicin—stomach cancer	0.000136	0.00115	CcSEcCtD
Dabigatran etexilate—Bronchitis—Doxorubicin—stomach cancer	0.000136	0.00115	CcSEcCtD
Dabigatran etexilate—Palpitations—Capecitabine—stomach cancer	0.000135	0.00114	CcSEcCtD
Dabigatran etexilate—Arthralgia—Docetaxel—stomach cancer	0.000134	0.00114	CcSEcCtD
Dabigatran etexilate—Chest pain—Docetaxel—stomach cancer	0.000134	0.00114	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Capecitabine—stomach cancer	0.000134	0.00114	CcSEcCtD
Dabigatran etexilate—Asthenia—Irinotecan—stomach cancer	0.000134	0.00113	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000133	0.00113	CcSEcCtD
Dabigatran etexilate—Cough—Capecitabine—stomach cancer	0.000133	0.00113	CcSEcCtD
Dabigatran etexilate—Urinary tract infection—Epirubicin—stomach cancer	0.000132	0.00112	CcSEcCtD
Dabigatran etexilate—Hypertension—Capecitabine—stomach cancer	0.000132	0.00112	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Fluorouracil—stomach cancer	0.000131	0.00111	CcSEcCtD
Dabigatran etexilate—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000131	0.00111	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Methotrexate—stomach cancer	0.000131	0.00111	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Methotrexate—stomach cancer	0.000131	0.00111	CcSEcCtD
Dabigatran etexilate—Arthralgia—Capecitabine—stomach cancer	0.00013	0.0011	CcSEcCtD
Dabigatran etexilate—Chest pain—Capecitabine—stomach cancer	0.00013	0.0011	CcSEcCtD
Dabigatran etexilate—Haematuria—Epirubicin—stomach cancer	0.00013	0.0011	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000129	0.00109	CcSEcCtD
Dabigatran etexilate—Urinary tract disorder—Methotrexate—stomach cancer	0.000129	0.00109	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Epirubicin—stomach cancer	0.000129	0.00109	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Docetaxel—stomach cancer	0.000129	0.00109	CcSEcCtD
Dabigatran etexilate—Epistaxis—Epirubicin—stomach cancer	0.000128	0.00109	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Methotrexate—stomach cancer	0.000128	0.00108	CcSEcCtD
Dabigatran etexilate—Infection—Docetaxel—stomach cancer	0.000128	0.00108	CcSEcCtD
Dabigatran etexilate—Sinusitis—Epirubicin—stomach cancer	0.000128	0.00108	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Irinotecan—stomach cancer	0.000127	0.00108	CcSEcCtD
Dabigatran etexilate—Pneumonia—Doxorubicin—stomach cancer	0.000127	0.00107	CcSEcCtD
Dabigatran etexilate—Shock—Docetaxel—stomach cancer	0.000127	0.00107	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Docetaxel—stomach cancer	0.000126	0.00107	CcSEcCtD
Dabigatran etexilate—Pruritus—Fluorouracil—stomach cancer	0.000126	0.00107	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Docetaxel—stomach cancer	0.000126	0.00107	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Doxorubicin—stomach cancer	0.000126	0.00107	CcSEcCtD
Dabigatran etexilate—Infestation—Doxorubicin—stomach cancer	0.000126	0.00107	CcSEcCtD
Dabigatran etexilate—ABCB1—lymph node—stomach cancer	0.000126	0.00131	CbGeAlD
Dabigatran etexilate—Skin disorder—Docetaxel—stomach cancer	0.000125	0.00106	CcSEcCtD
Dabigatran etexilate—Infection—Capecitabine—stomach cancer	0.000124	0.00105	CcSEcCtD
Dabigatran etexilate—Dizziness—Irinotecan—stomach cancer	0.000123	0.00104	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Epirubicin—stomach cancer	0.000123	0.00104	CcSEcCtD
Dabigatran etexilate—Shock—Capecitabine—stomach cancer	0.000123	0.00104	CcSEcCtD
Dabigatran etexilate—Urinary tract infection—Doxorubicin—stomach cancer	0.000122	0.00104	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Capecitabine—stomach cancer	0.000122	0.00103	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Epirubicin—stomach cancer	0.000122	0.00103	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Fluorouracil—stomach cancer	0.000122	0.00103	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Capecitabine—stomach cancer	0.000122	0.00103	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Methotrexate—stomach cancer	0.000121	0.00103	CcSEcCtD
Dabigatran etexilate—Skin disorder—Capecitabine—stomach cancer	0.000121	0.00102	CcSEcCtD
Dabigatran etexilate—Urinary tract disorder—Epirubicin—stomach cancer	0.000121	0.00102	CcSEcCtD
Dabigatran etexilate—Oedema peripheral—Epirubicin—stomach cancer	0.00012	0.00102	CcSEcCtD
Dabigatran etexilate—Hypotension—Docetaxel—stomach cancer	0.00012	0.00102	CcSEcCtD
Dabigatran etexilate—Haematuria—Doxorubicin—stomach cancer	0.00012	0.00102	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Epirubicin—stomach cancer	0.00012	0.00102	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Epirubicin—stomach cancer	0.00012	0.00101	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000119	0.00101	CcSEcCtD
Dabigatran etexilate—Epistaxis—Doxorubicin—stomach cancer	0.000119	0.00101	CcSEcCtD
Dabigatran etexilate—Angiopathy—Methotrexate—stomach cancer	0.000118	0.001	CcSEcCtD
Dabigatran etexilate—Vomiting—Irinotecan—stomach cancer	0.000118	0.001	CcSEcCtD
Dabigatran etexilate—Sinusitis—Doxorubicin—stomach cancer	0.000118	0.001	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Methotrexate—stomach cancer	0.000118	0.000999	CcSEcCtD
Dabigatran etexilate—Dizziness—Fluorouracil—stomach cancer	0.000118	0.000999	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Methotrexate—stomach cancer	0.000118	0.000996	CcSEcCtD
Dabigatran etexilate—Rash—Irinotecan—stomach cancer	0.000117	0.000994	CcSEcCtD
Dabigatran etexilate—Dermatitis—Irinotecan—stomach cancer	0.000117	0.000993	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000117	0.000993	CcSEcCtD
Dabigatran etexilate—Headache—Irinotecan—stomach cancer	0.000117	0.000988	CcSEcCtD
Dabigatran etexilate—Hypotension—Capecitabine—stomach cancer	0.000116	0.000986	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Docetaxel—stomach cancer	0.000115	0.000972	CcSEcCtD
Dabigatran etexilate—Malnutrition—Methotrexate—stomach cancer	0.000114	0.000962	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Doxorubicin—stomach cancer	0.000114	0.000962	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000114	0.000961	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Epirubicin—stomach cancer	0.000113	0.00096	CcSEcCtD
Dabigatran etexilate—Vomiting—Fluorouracil—stomach cancer	0.000113	0.00096	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Docetaxel—stomach cancer	0.000113	0.000959	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Doxorubicin—stomach cancer	0.000113	0.000957	CcSEcCtD
Dabigatran etexilate—Rash—Fluorouracil—stomach cancer	0.000112	0.000952	CcSEcCtD
Dabigatran etexilate—Dermatitis—Fluorouracil—stomach cancer	0.000112	0.000951	CcSEcCtD
Dabigatran etexilate—Headache—Fluorouracil—stomach cancer	0.000112	0.000946	CcSEcCtD
Dabigatran etexilate—Urinary tract disorder—Doxorubicin—stomach cancer	0.000112	0.000945	CcSEcCtD
Dabigatran etexilate—Oedema peripheral—Doxorubicin—stomach cancer	0.000111	0.000943	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000111	0.000941	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Doxorubicin—stomach cancer	0.000111	0.000941	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Capecitabine—stomach cancer	0.000111	0.000941	CcSEcCtD
Dabigatran etexilate—Fatigue—Docetaxel—stomach cancer	0.000111	0.00094	CcSEcCtD
Dabigatran etexilate—Angiopathy—Epirubicin—stomach cancer	0.000111	0.000939	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Doxorubicin—stomach cancer	0.000111	0.000939	CcSEcCtD
Dabigatran etexilate—Nausea—Irinotecan—stomach cancer	0.000111	0.000937	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Epirubicin—stomach cancer	0.00011	0.000935	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Epirubicin—stomach cancer	0.00011	0.000933	CcSEcCtD
Dabigatran etexilate—Constipation—Docetaxel—stomach cancer	0.00011	0.000932	CcSEcCtD
Dabigatran etexilate—Back pain—Methotrexate—stomach cancer	0.00011	0.000931	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Capecitabine—stomach cancer	0.00011	0.000929	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000108	0.000911	CcSEcCtD
Dabigatran etexilate—Fatigue—Capecitabine—stomach cancer	0.000107	0.00091	CcSEcCtD
Dabigatran etexilate—Constipation—Capecitabine—stomach cancer	0.000107	0.000902	CcSEcCtD
Dabigatran etexilate—Malnutrition—Epirubicin—stomach cancer	0.000106	0.000901	CcSEcCtD
Dabigatran etexilate—Nausea—Fluorouracil—stomach cancer	0.000106	0.000897	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Docetaxel—stomach cancer	0.000105	0.000891	CcSEcCtD
Dabigatran etexilate—Anaemia—Methotrexate—stomach cancer	0.000105	0.00089	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Doxorubicin—stomach cancer	0.000105	0.000889	CcSEcCtD
Dabigatran etexilate—Flatulence—Epirubicin—stomach cancer	0.000105	0.000888	CcSEcCtD
Dabigatran etexilate—Back pain—Epirubicin—stomach cancer	0.000103	0.000871	CcSEcCtD
Dabigatran etexilate—Angiopathy—Doxorubicin—stomach cancer	0.000103	0.000869	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Doxorubicin—stomach cancer	0.000102	0.000865	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Capecitabine—stomach cancer	0.000102	0.000863	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Doxorubicin—stomach cancer	0.000102	0.000863	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Docetaxel—stomach cancer	0.000102	0.000862	CcSEcCtD
Dabigatran etexilate—Cough—Methotrexate—stomach cancer	9.92e-05	0.00084	CcSEcCtD
Dabigatran etexilate—Urticaria—Capecitabine—stomach cancer	9.9e-05	0.000838	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Capecitabine—stomach cancer	9.85e-05	0.000834	CcSEcCtD
Dabigatran etexilate—Malnutrition—Doxorubicin—stomach cancer	9.84e-05	0.000833	CcSEcCtD
Dabigatran etexilate—Anaemia—Epirubicin—stomach cancer	9.83e-05	0.000833	CcSEcCtD
Dabigatran etexilate—Flatulence—Doxorubicin—stomach cancer	9.7e-05	0.000821	CcSEcCtD
Dabigatran etexilate—Arthralgia—Methotrexate—stomach cancer	9.68e-05	0.000819	CcSEcCtD
Dabigatran etexilate—Chest pain—Methotrexate—stomach cancer	9.68e-05	0.000819	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	9.61e-05	0.000814	CcSEcCtD
Dabigatran etexilate—Syncope—Epirubicin—stomach cancer	9.54e-05	0.000808	CcSEcCtD
Dabigatran etexilate—Back pain—Doxorubicin—stomach cancer	9.52e-05	0.000806	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Docetaxel—stomach cancer	9.48e-05	0.000803	CcSEcCtD
Dabigatran etexilate—Palpitations—Epirubicin—stomach cancer	9.4e-05	0.000796	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Epirubicin—stomach cancer	9.35e-05	0.000792	CcSEcCtD
Dabigatran etexilate—Cough—Epirubicin—stomach cancer	9.28e-05	0.000786	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Methotrexate—stomach cancer	9.28e-05	0.000786	CcSEcCtD
Dabigatran etexilate—Asthenia—Docetaxel—stomach cancer	9.24e-05	0.000782	CcSEcCtD
Dabigatran etexilate—Infection—Methotrexate—stomach cancer	9.22e-05	0.00078	CcSEcCtD
Dabigatran etexilate—Hypertension—Epirubicin—stomach cancer	9.19e-05	0.000778	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Capecitabine—stomach cancer	9.18e-05	0.000777	CcSEcCtD
Dabigatran etexilate—Pruritus—Docetaxel—stomach cancer	9.11e-05	0.000771	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Methotrexate—stomach cancer	9.1e-05	0.00077	CcSEcCtD
Dabigatran etexilate—Anaemia—Doxorubicin—stomach cancer	9.1e-05	0.00077	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Methotrexate—stomach cancer	9.08e-05	0.000769	CcSEcCtD
Dabigatran etexilate—Arthralgia—Epirubicin—stomach cancer	9.06e-05	0.000767	CcSEcCtD
Dabigatran etexilate—Chest pain—Epirubicin—stomach cancer	9.06e-05	0.000767	CcSEcCtD
Dabigatran etexilate—Skin disorder—Methotrexate—stomach cancer	9.01e-05	0.000763	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	9e-05	0.000762	CcSEcCtD
Dabigatran etexilate—Asthenia—Capecitabine—stomach cancer	8.94e-05	0.000757	CcSEcCtD
Dabigatran etexilate—Syncope—Doxorubicin—stomach cancer	8.83e-05	0.000747	CcSEcCtD
Dabigatran etexilate—Pruritus—Capecitabine—stomach cancer	8.82e-05	0.000747	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Docetaxel—stomach cancer	8.81e-05	0.000746	CcSEcCtD
Dabigatran etexilate—Palpitations—Doxorubicin—stomach cancer	8.7e-05	0.000737	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Epirubicin—stomach cancer	8.68e-05	0.000735	CcSEcCtD
Dabigatran etexilate—Hypotension—Methotrexate—stomach cancer	8.67e-05	0.000734	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Doxorubicin—stomach cancer	8.65e-05	0.000733	CcSEcCtD
Dabigatran etexilate—Infection—Epirubicin—stomach cancer	8.63e-05	0.00073	CcSEcCtD
Dabigatran etexilate—Cough—Doxorubicin—stomach cancer	8.59e-05	0.000727	CcSEcCtD
Dabigatran etexilate—Shock—Epirubicin—stomach cancer	8.54e-05	0.000723	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Capecitabine—stomach cancer	8.53e-05	0.000722	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Epirubicin—stomach cancer	8.52e-05	0.000721	CcSEcCtD
Dabigatran etexilate—Dizziness—Docetaxel—stomach cancer	8.51e-05	0.000721	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Epirubicin—stomach cancer	8.5e-05	0.00072	CcSEcCtD
Dabigatran etexilate—Hypertension—Doxorubicin—stomach cancer	8.5e-05	0.00072	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Methotrexate—stomach cancer	8.45e-05	0.000716	CcSEcCtD
Dabigatran etexilate—Skin disorder—Epirubicin—stomach cancer	8.43e-05	0.000714	CcSEcCtD
Dabigatran etexilate—Arthralgia—Doxorubicin—stomach cancer	8.38e-05	0.00071	CcSEcCtD
Dabigatran etexilate—Chest pain—Doxorubicin—stomach cancer	8.38e-05	0.00071	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	8.32e-05	0.000705	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Methotrexate—stomach cancer	8.27e-05	0.0007	CcSEcCtD
Dabigatran etexilate—Dizziness—Capecitabine—stomach cancer	8.24e-05	0.000698	CcSEcCtD
Dabigatran etexilate—Vomiting—Docetaxel—stomach cancer	8.19e-05	0.000693	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Methotrexate—stomach cancer	8.17e-05	0.000691	CcSEcCtD
Dabigatran etexilate—Rash—Docetaxel—stomach cancer	8.12e-05	0.000687	CcSEcCtD
Dabigatran etexilate—Hypotension—Epirubicin—stomach cancer	8.11e-05	0.000687	CcSEcCtD
Dabigatran etexilate—Dermatitis—Docetaxel—stomach cancer	8.11e-05	0.000687	CcSEcCtD
Dabigatran etexilate—Headache—Docetaxel—stomach cancer	8.06e-05	0.000683	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Doxorubicin—stomach cancer	8.03e-05	0.00068	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Methotrexate—stomach cancer	8.01e-05	0.000678	CcSEcCtD
Dabigatran etexilate—Fatigue—Methotrexate—stomach cancer	8e-05	0.000677	CcSEcCtD
Dabigatran etexilate—Infection—Doxorubicin—stomach cancer	7.98e-05	0.000676	CcSEcCtD
Dabigatran etexilate—Vomiting—Capecitabine—stomach cancer	7.92e-05	0.000671	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Epirubicin—stomach cancer	7.91e-05	0.00067	CcSEcCtD
Dabigatran etexilate—Shock—Doxorubicin—stomach cancer	7.9e-05	0.000669	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Doxorubicin—stomach cancer	7.88e-05	0.000667	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Doxorubicin—stomach cancer	7.87e-05	0.000666	CcSEcCtD
Dabigatran etexilate—Rash—Capecitabine—stomach cancer	7.86e-05	0.000665	CcSEcCtD
Dabigatran etexilate—Dermatitis—Capecitabine—stomach cancer	7.85e-05	0.000665	CcSEcCtD
Dabigatran etexilate—Headache—Capecitabine—stomach cancer	7.81e-05	0.000661	CcSEcCtD
Dabigatran etexilate—Skin disorder—Doxorubicin—stomach cancer	7.8e-05	0.000661	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Epirubicin—stomach cancer	7.74e-05	0.000655	CcSEcCtD
Dabigatran etexilate—Nausea—Docetaxel—stomach cancer	7.65e-05	0.000647	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Epirubicin—stomach cancer	7.64e-05	0.000647	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Methotrexate—stomach cancer	7.59e-05	0.000642	CcSEcCtD
Dabigatran etexilate—Hypotension—Doxorubicin—stomach cancer	7.51e-05	0.000636	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Epirubicin—stomach cancer	7.5e-05	0.000635	CcSEcCtD
Dabigatran etexilate—Fatigue—Epirubicin—stomach cancer	7.49e-05	0.000634	CcSEcCtD
Dabigatran etexilate—Constipation—Epirubicin—stomach cancer	7.43e-05	0.000629	CcSEcCtD
Dabigatran etexilate—Nausea—Capecitabine—stomach cancer	7.4e-05	0.000627	CcSEcCtD
Dabigatran etexilate—Urticaria—Methotrexate—stomach cancer	7.37e-05	0.000624	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Methotrexate—stomach cancer	7.33e-05	0.000621	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Doxorubicin—stomach cancer	7.32e-05	0.00062	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Doxorubicin—stomach cancer	7.16e-05	0.000606	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Epirubicin—stomach cancer	7.1e-05	0.000601	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Doxorubicin—stomach cancer	7.07e-05	0.000599	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Doxorubicin—stomach cancer	6.94e-05	0.000587	CcSEcCtD
Dabigatran etexilate—Fatigue—Doxorubicin—stomach cancer	6.93e-05	0.000586	CcSEcCtD
Dabigatran etexilate—Urticaria—Epirubicin—stomach cancer	6.9e-05	0.000584	CcSEcCtD
Dabigatran etexilate—Constipation—Doxorubicin—stomach cancer	6.87e-05	0.000582	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Epirubicin—stomach cancer	6.86e-05	0.000581	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Methotrexate—stomach cancer	6.84e-05	0.000579	CcSEcCtD
Dabigatran etexilate—Asthenia—Methotrexate—stomach cancer	6.66e-05	0.000564	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Doxorubicin—stomach cancer	6.57e-05	0.000556	CcSEcCtD
Dabigatran etexilate—Pruritus—Methotrexate—stomach cancer	6.56e-05	0.000556	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Epirubicin—stomach cancer	6.4e-05	0.000542	CcSEcCtD
Dabigatran etexilate—Urticaria—Doxorubicin—stomach cancer	6.38e-05	0.00054	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Doxorubicin—stomach cancer	6.35e-05	0.000538	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Methotrexate—stomach cancer	6.35e-05	0.000537	CcSEcCtD
Dabigatran etexilate—Asthenia—Epirubicin—stomach cancer	6.23e-05	0.000527	CcSEcCtD
Dabigatran etexilate—Pruritus—Epirubicin—stomach cancer	6.14e-05	0.00052	CcSEcCtD
Dabigatran etexilate—Dizziness—Methotrexate—stomach cancer	6.14e-05	0.000519	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Epirubicin—stomach cancer	5.94e-05	0.000503	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Doxorubicin—stomach cancer	5.92e-05	0.000501	CcSEcCtD
Dabigatran etexilate—Vomiting—Methotrexate—stomach cancer	5.9e-05	0.000499	CcSEcCtD
Dabigatran etexilate—Rash—Methotrexate—stomach cancer	5.85e-05	0.000495	CcSEcCtD
Dabigatran etexilate—Dermatitis—Methotrexate—stomach cancer	5.84e-05	0.000495	CcSEcCtD
Dabigatran etexilate—Headache—Methotrexate—stomach cancer	5.81e-05	0.000492	CcSEcCtD
Dabigatran etexilate—Asthenia—Doxorubicin—stomach cancer	5.76e-05	0.000488	CcSEcCtD
Dabigatran etexilate—Dizziness—Epirubicin—stomach cancer	5.74e-05	0.000486	CcSEcCtD
Dabigatran etexilate—Pruritus—Doxorubicin—stomach cancer	5.68e-05	0.000481	CcSEcCtD
Dabigatran etexilate—Vomiting—Epirubicin—stomach cancer	5.52e-05	0.000467	CcSEcCtD
Dabigatran etexilate—Nausea—Methotrexate—stomach cancer	5.51e-05	0.000467	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Doxorubicin—stomach cancer	5.5e-05	0.000465	CcSEcCtD
Dabigatran etexilate—Rash—Epirubicin—stomach cancer	5.47e-05	0.000464	CcSEcCtD
Dabigatran etexilate—Dermatitis—Epirubicin—stomach cancer	5.47e-05	0.000463	CcSEcCtD
Dabigatran etexilate—Headache—Epirubicin—stomach cancer	5.44e-05	0.000461	CcSEcCtD
Dabigatran etexilate—Dizziness—Doxorubicin—stomach cancer	5.31e-05	0.00045	CcSEcCtD
Dabigatran etexilate—Nausea—Epirubicin—stomach cancer	5.16e-05	0.000437	CcSEcCtD
Dabigatran etexilate—Vomiting—Doxorubicin—stomach cancer	5.11e-05	0.000432	CcSEcCtD
Dabigatran etexilate—Rash—Doxorubicin—stomach cancer	5.07e-05	0.000429	CcSEcCtD
Dabigatran etexilate—Dermatitis—Doxorubicin—stomach cancer	5.06e-05	0.000428	CcSEcCtD
Dabigatran etexilate—Headache—Doxorubicin—stomach cancer	5.03e-05	0.000426	CcSEcCtD
Dabigatran etexilate—Nausea—Doxorubicin—stomach cancer	4.77e-05	0.000404	CcSEcCtD
Dabigatran etexilate—F2—Signaling by GPCR—ANXA1—stomach cancer	3e-05	0.00031	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ALDH7A1—stomach cancer	2.98e-05	0.000308	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PLCE1—stomach cancer	2.98e-05	0.000308	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—CAV1—stomach cancer	2.96e-05	0.000306	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—MAPK3—stomach cancer	2.95e-05	0.000306	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—APOA1—stomach cancer	2.95e-05	0.000305	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—KISS1—stomach cancer	2.93e-05	0.000303	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RNF43—stomach cancer	2.93e-05	0.000303	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL1B—stomach cancer	2.92e-05	0.000302	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	2.91e-05	0.000301	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—ADRB1—stomach cancer	2.91e-05	0.000301	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—stomach cancer	2.88e-05	0.000298	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—SREBF2—stomach cancer	2.87e-05	0.000297	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	2.87e-05	0.000297	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	2.87e-05	0.000297	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—VEGFA—stomach cancer	2.86e-05	0.000295	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—UMPS—stomach cancer	2.85e-05	0.000295	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—RORA—stomach cancer	2.84e-05	0.000294	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—stomach cancer	2.83e-05	0.000293	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—ERCC2—stomach cancer	2.83e-05	0.000293	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—PRKCB—stomach cancer	2.81e-05	0.000291	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	2.81e-05	0.000291	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ACAD8—stomach cancer	2.8e-05	0.000289	CbGpPWpGaD
Dabigatran etexilate—F2—G alpha (q) signalling events—PIK3CA—stomach cancer	2.79e-05	0.000288	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	2.78e-05	0.000287	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	2.71e-05	0.000281	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ALDOB—stomach cancer	2.66e-05	0.000275	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—MTHFR—stomach cancer	2.66e-05	0.000275	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PDHA1—stomach cancer	2.65e-05	0.000274	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ECHS1—stomach cancer	2.65e-05	0.000274	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—FST—stomach cancer	2.61e-05	0.00027	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	2.6e-05	0.000269	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—ADRB2—stomach cancer	2.59e-05	0.000268	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—HBEGF—stomach cancer	2.55e-05	0.000264	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RGS2—stomach cancer	2.52e-05	0.00026	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GAST—stomach cancer	2.52e-05	0.00026	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—TYMP—stomach cancer	2.49e-05	0.000258	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—FADS1—stomach cancer	2.49e-05	0.000258	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	2.49e-05	0.000258	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GMPR2—stomach cancer	2.49e-05	0.000258	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ALOX5—stomach cancer	2.47e-05	0.000256	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—VEGFA—stomach cancer	2.47e-05	0.000256	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—CAV1—stomach cancer	2.45e-05	0.000254	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—APOA1—stomach cancer	2.45e-05	0.000253	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	2.44e-05	0.000252	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—DPYD—stomach cancer	2.43e-05	0.000252	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—FGG—stomach cancer	2.39e-05	0.000247	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—ADRB2—stomach cancer	2.36e-05	0.000244	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—SERPINE1—stomach cancer	2.34e-05	0.000242	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—ALB—stomach cancer	2.34e-05	0.000242	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SREBF2—stomach cancer	2.34e-05	0.000241	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PPP2R1A—stomach cancer	2.31e-05	0.000239	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—RORA—stomach cancer	2.31e-05	0.000239	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	2.31e-05	0.000239	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PRKAA1—stomach cancer	2.3e-05	0.000237	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—IDH3B—stomach cancer	2.28e-05	0.000236	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SUCLG1—stomach cancer	2.28e-05	0.000236	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—RHOA—stomach cancer	2.26e-05	0.000233	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—NOS3—stomach cancer	2.23e-05	0.000231	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RBP4—stomach cancer	2.22e-05	0.000229	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CXCL8—stomach cancer	2.22e-05	0.000229	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	2.21e-05	0.000228	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	2.17e-05	0.000224	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ALDOB—stomach cancer	2.16e-05	0.000224	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PPARG—stomach cancer	2.16e-05	0.000223	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GSTT1—stomach cancer	2.15e-05	0.000223	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CYP2A6—stomach cancer	2.13e-05	0.00022	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—TNF—stomach cancer	2.12e-05	0.000219	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NDUFS1—stomach cancer	2.12e-05	0.000219	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NDUFV1—stomach cancer	2.12e-05	0.000219	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—AKR1C3—stomach cancer	2.07e-05	0.000214	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	2.04e-05	0.000211	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.04e-05	0.000211	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.03e-05	0.00021	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ENO1—stomach cancer	2.02e-05	0.000209	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ALOX5—stomach cancer	2.01e-05	0.000208	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—DPYD—stomach cancer	1.98e-05	0.000205	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—ALB—stomach cancer	1.94e-05	0.000201	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AGTR2—stomach cancer	1.91e-05	0.000197	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HSPB1—stomach cancer	1.91e-05	0.000197	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	1.9e-05	0.000197	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PGLS—stomach cancer	1.89e-05	0.000195	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—BLVRB—stomach cancer	1.89e-05	0.000195	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—BMP2—stomach cancer	1.89e-05	0.000195	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—F2R—stomach cancer	1.89e-05	0.000195	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—MMP2—stomach cancer	1.88e-05	0.000194	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AKR1C3—stomach cancer	1.86e-05	0.000192	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—NOS3—stomach cancer	1.86e-05	0.000192	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HTR1A—stomach cancer	1.84e-05	0.00019	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPAP2A—stomach cancer	1.8e-05	0.000186	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.79e-05	0.000185	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CD44—stomach cancer	1.79e-05	0.000185	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—PRKCB—stomach cancer	1.78e-05	0.000184	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ANXA1—stomach cancer	1.77e-05	0.000183	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GSTT1—stomach cancer	1.75e-05	0.000181	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CYP2A6—stomach cancer	1.73e-05	0.000179	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ADRB1—stomach cancer	1.72e-05	0.000178	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PTGS2—stomach cancer	1.7e-05	0.000175	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—AKR1C3—stomach cancer	1.68e-05	0.000174	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RPS6—stomach cancer	1.64e-05	0.00017	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ENO1—stomach cancer	1.64e-05	0.000169	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PRKCB—stomach cancer	1.61e-05	0.000167	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.61e-05	0.000167	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—VEGFA—stomach cancer	1.61e-05	0.000166	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IL6ST—stomach cancer	1.61e-05	0.000166	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CA1—stomach cancer	1.61e-05	0.000166	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CKB—stomach cancer	1.61e-05	0.000166	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—FBP1—stomach cancer	1.61e-05	0.000166	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NDUFA2—stomach cancer	1.61e-05	0.000166	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	1.58e-05	0.000164	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—CXCL8—stomach cancer	1.56e-05	0.000161	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	1.55e-05	0.00016	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—MAPK3—stomach cancer	1.52e-05	0.000157	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PPP2R1A—stomach cancer	1.52e-05	0.000157	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PLIN2—stomach cancer	1.51e-05	0.000156	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HBEGF—stomach cancer	1.51e-05	0.000156	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GSTP1—stomach cancer	1.49e-05	0.000154	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—HMOX1—stomach cancer	1.47e-05	0.000152	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CA2—stomach cancer	1.47e-05	0.000152	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	1.47e-05	0.000152	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CD44—stomach cancer	1.45e-05	0.00015	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—MAPK1—stomach cancer	1.45e-05	0.00015	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IL6R—stomach cancer	1.43e-05	0.000148	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NT5E—stomach cancer	1.43e-05	0.000148	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PGAM1—stomach cancer	1.43e-05	0.000148	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—RHOA—stomach cancer	1.43e-05	0.000148	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.41e-05	0.000146	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	1.4e-05	0.000145	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	1.4e-05	0.000144	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ADRB2—stomach cancer	1.39e-05	0.000144	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—TYMS—stomach cancer	1.39e-05	0.000143	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GSTM1—stomach cancer	1.37e-05	0.000142	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—KRAS—stomach cancer	1.37e-05	0.000142	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ALDH7A1—stomach cancer	1.37e-05	0.000141	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PLCE1—stomach cancer	1.37e-05	0.000141	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PPP2R1A—stomach cancer	1.36e-05	0.000141	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	1.35e-05	0.00014	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	1.32e-05	0.000137	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—UMPS—stomach cancer	1.31e-05	0.000135	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—RHOA—stomach cancer	1.3e-05	0.000134	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ERCC2—stomach cancer	1.29e-05	0.000133	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SMAD4—stomach cancer	1.27e-05	0.000131	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—PIK3CA—stomach cancer	1.26e-05	0.00013	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CXCL8—stomach cancer	1.25e-05	0.00013	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PPP2R1A—stomach cancer	1.24e-05	0.000128	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	1.22e-05	0.000126	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PDHA1—stomach cancer	1.22e-05	0.000126	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ECHS1—stomach cancer	1.22e-05	0.000126	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—TP53—stomach cancer	1.22e-05	0.000126	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GSTP1—stomach cancer	1.21e-05	0.000125	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—MTHFR—stomach cancer	1.21e-05	0.000125	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—FYN—stomach cancer	1.2e-05	0.000124	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—HMOX1—stomach cancer	1.2e-05	0.000124	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.17e-05	0.000121	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—HRAS—stomach cancer	1.16e-05	0.00012	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	1.15e-05	0.000119	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—TYMP—stomach cancer	1.14e-05	0.000118	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—FADS1—stomach cancer	1.14e-05	0.000118	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CXCL8—stomach cancer	1.14e-05	0.000118	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—FGFR2—stomach cancer	1.13e-05	0.000117	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—TYMS—stomach cancer	1.13e-05	0.000117	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	1.12e-05	0.000116	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CAV1—stomach cancer	1.12e-05	0.000116	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—APOA1—stomach cancer	1.12e-05	0.000115	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GSTM1—stomach cancer	1.11e-05	0.000115	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	1.1e-05	0.000114	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	1.1e-05	0.000114	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SREBF2—stomach cancer	1.07e-05	0.000111	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—RORA—stomach cancer	1.06e-05	0.000109	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ERCC2—stomach cancer	1.05e-05	0.000108	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	1.05e-05	0.000108	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PIK3CA—stomach cancer	1.04e-05	0.000108	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	1.04e-05	0.000107	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IRS2—stomach cancer	1.03e-05	0.000107	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CAV1—stomach cancer	1e-05	0.000104	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—APOA1—stomach cancer	1e-05	0.000103	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ALDOB—stomach cancer	9.92e-06	0.000103	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—MTHFR—stomach cancer	9.85e-06	0.000102	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PPARG—stomach cancer	9.83e-06	0.000102	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PRKCB—stomach cancer	9.54e-06	9.86e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	9.53e-06	9.86e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL6ST—stomach cancer	9.5e-06	9.82e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ALOX5—stomach cancer	9.22e-06	9.54e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	9.22e-06	9.53e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—APC—stomach cancer	9.13e-06	9.44e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CAV1—stomach cancer	9.08e-06	9.39e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—DPYD—stomach cancer	9.07e-06	9.38e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—APOA1—stomach cancer	9.06e-06	9.37e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	8.87e-06	9.18e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ALB—stomach cancer	8.83e-06	9.13e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—MAPK3—stomach cancer	8.74e-06	9.04e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	8.68e-06	8.97e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL6R—stomach cancer	8.47e-06	8.76e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—NOS3—stomach cancer	8.45e-06	8.74e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—MAPK1—stomach cancer	8.32e-06	8.6e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—EGFR—stomach cancer	8.32e-06	8.6e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GSTT1—stomach cancer	8.02e-06	8.3e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PPARG—stomach cancer	7.98e-06	8.25e-05	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—PIK3CA—stomach cancer	7.95e-06	8.22e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SERPINE1—stomach cancer	7.94e-06	8.21e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYP2A6—stomach cancer	7.93e-06	8.2e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—KRAS—stomach cancer	7.86e-06	8.12e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PTGS2—stomach cancer	7.73e-06	7.99e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—AKR1C3—stomach cancer	7.71e-06	7.98e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RHOA—stomach cancer	7.66e-06	7.92e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NOS3—stomach cancer	7.58e-06	7.83e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ENO1—stomach cancer	7.52e-06	7.77e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PIK3CA—stomach cancer	7.22e-06	7.46e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ALB—stomach cancer	7.18e-06	7.42e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ERBB2—stomach cancer	7.09e-06	7.33e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	7.03e-06	7.27e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—NOS3—stomach cancer	6.87e-06	7.1e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CXCL8—stomach cancer	6.72e-06	6.95e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—HRAS—stomach cancer	6.68e-06	6.9e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CD44—stomach cancer	6.67e-06	6.89e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CDKN1B—stomach cancer	6.56e-06	6.79e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IL6—stomach cancer	6.39e-06	6.61e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PTGS2—stomach cancer	6.28e-06	6.49e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCND1—stomach cancer	6.26e-06	6.47e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—JUN—stomach cancer	6.25e-06	6.46e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MMP9—stomach cancer	6.08e-06	6.29e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CDKN1A—stomach cancer	6.06e-06	6.26e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MAPK8—stomach cancer	5.91e-06	6.11e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPP2R1A—stomach cancer	5.67e-06	5.86e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GSTP1—stomach cancer	5.56e-06	5.75e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HMOX1—stomach cancer	5.48e-06	5.67e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—VEGFA—stomach cancer	5.46e-06	5.64e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—STAT3—stomach cancer	5.4e-06	5.59e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—TYMS—stomach cancer	5.17e-06	5.35e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MAPK3—stomach cancer	5.16e-06	5.34e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GSTM1—stomach cancer	5.11e-06	5.28e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MYC—stomach cancer	5.02e-06	5.19e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MAPK1—stomach cancer	4.91e-06	5.08e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—EGFR—stomach cancer	4.91e-06	5.08e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ERCC2—stomach cancer	4.8e-06	4.97e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PIK3CA—stomach cancer	4.76e-06	4.92e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—KRAS—stomach cancer	4.64e-06	4.8e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—MTHFR—stomach cancer	4.52e-06	4.67e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PIK3CA—stomach cancer	4.26e-06	4.41e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CAV1—stomach cancer	4.17e-06	4.31e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—APOA1—stomach cancer	4.16e-06	4.3e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TP53—stomach cancer	4.12e-06	4.26e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HRAS—stomach cancer	3.94e-06	4.08e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PIK3CA—stomach cancer	3.86e-06	4e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL6—stomach cancer	3.78e-06	3.9e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPARG—stomach cancer	3.66e-06	3.79e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ALB—stomach cancer	3.29e-06	3.41e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NOS3—stomach cancer	3.15e-06	3.26e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PTGS2—stomach cancer	2.88e-06	2.98e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PIK3CA—stomach cancer	1.77e-06	1.83e-05	CbGpPWpGaD
